Antibiotic level of resistance is a major community wellness in European countries and globally. Indeed, it improves deaths and death rate due to communicable illnesses, leading to a destruction in the lifestyle and increased costs in medical and wellness health care.
Antibiotics are essential to battle against infected illnesses. It is therefore crucial to retain the potency of medication that are still efficient.
Antibiotic level of resistance and the various factors that have allowed it to grow requires a multidisciplinary approach and multisectoral. In this place, national projects are not sufficient to reduce risks, and effectively avoid the micro-organisms becoming immune to medications used in individual and vet medication and pet nourish, or to retain the potency of medications in the treatment of infected illnesses. A common technique and synchronized activity is therefore required at Group and globally.
Given the global aspect of this issue, it is necessary that Participant Declares and the Commission payment are definitely giving the is designed of this resolution by globally companies, in particular by the World Health Company (WHO ), the UN Meals and Farming Company (FAO) and the Office International des Epizooties (OIE).
In the Commission's overall technique should be based on a risk evaluation and consist of a synchronized management and precautionary activity (eg, tracking of anti-biotic level of resistance and its repercussions in people and creatures and in food, battle against bacterial infections in health health care and animals development, growth of new healing and precautionary drugs etc..) and analysis (including the effects of safety measures, the growth of new medications and of alternatives, improved use of medications, systems of the spread and growth of anti-biotic level of resistance or even the best management methods to improve the wellness of animals).
As part of this technique, Participant Declares are welcomed to:
The Commission payment is welcomed to:
Antibiotics are essential to battle against infected illnesses. It is therefore crucial to retain the potency of medication that are still efficient.
Antibiotic level of resistance and the various factors that have allowed it to grow requires a multidisciplinary approach and multisectoral. In this place, national projects are not sufficient to reduce risks, and effectively avoid the micro-organisms becoming immune to medications used in individual and vet medication and pet nourish, or to retain the potency of medications in the treatment of infected illnesses. A common technique and synchronized activity is therefore required at Group and globally.
Given the global aspect of this issue, it is necessary that Participant Declares and the Commission payment are definitely giving the is designed of this resolution by globally companies, in particular by the World Health Company (WHO ), the UN Meals and Farming Company (FAO) and the Office International des Epizooties (OIE).
In the Commission's overall technique should be based on a risk evaluation and consist of a synchronized management and precautionary activity (eg, tracking of anti-biotic level of resistance and its repercussions in people and creatures and in food, battle against bacterial infections in health health care and animals development, growth of new healing and precautionary drugs etc..) and analysis (including the effects of safety measures, the growth of new medications and of alternatives, improved use of medications, systems of the spread and growth of anti-biotic level of resistance or even the best management methods to improve the wellness of animals).
As part of this technique, Participant Declares are welcomed to:
- develop multidisciplinary and multisectoral policies to help stop the growth of anti-biotic resistance;
- work to make sure efficient management and much like the supply and use of medications and an efficient similar tracking of anti-biotic resistance;
- protect the most crucial that medications whose use is certified in individual and vet medication, drugs are "prescription only" and to be cautious about the execution of this principle;
- enhance sticking with to the concepts of the battle against nosocomial bacterial infections as in non-hospital setting and in pet production;
- optimal suggesting and use of medications (through training of health health care experts, the book of guidelines, etc..) and to avoid needless or unsuitable uses in individual and vet medicine;
- enhance activities to increase awareness of health health care experts, farm owners and the community about the issue of anti-biotic resistance;
- enhance animals development systems concentrating on wellness, reducing the need for antibiotics;
- enhance analysis in this area;
- work closely with the Commission payment, such as in the above areas.
The Commission payment is welcomed to:
- consist of, as a priority, tracking of anti-biotic level of resistance in individual medication and in the battle against zoonoses and enhance complementarity of this tracking through the Group network for epidemiological tracking and the battle against communicable diseases;
- make sure, on the basis of similar data provided by Participant Declares, that a report be made on the supply and use of medications, such as individual and vet medication, as well as in pet nourish, the farming and other farming products and food, and to draw conclusions;
- support the exchange of encounters and information on the logical use of medications by appropriate community action;
- enhance, through the execution of the Fifth Structure Program, analysis on, for example on the development of anti-biotic level of resistance in bacterial communities and understanding of the transmissibility of proof bacteria in people in creatures and the environment;
- consider the advisability of developing a offer for a recommendation pursuant to the Treaty;
- consider whether it is necessary to change the current Group regulation in the field of individual and vet medicine;
- pay particular attention to the issue of anti-biotic level of resistance in specific wellness actions related to the selection countries, particularly in the Phare 2000;
The Commission payment shall enhance collaboration in close sychronisation with Participant Declares and relevant globally companies.
